Steven J. Mento - 24 Feb 2022 Form 4 Insider Report for Histogen Inc.

Role
Interim President and CEO, Director
Signature
/s/ Steven J. Mento
Issuer symbol
N/A
Transactions as of
24 Feb 2022
Net transactions value
$0
Form type
4
Filing time
25 Feb 2022, 15:40:48 UTC
Previous filing
05 Jan 2022
Next filing
09 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HSTO Stock Option (right to buy) Award $0 +151,642 $0.000000 151,642 24 Feb 2022 Common Stock 151,642 $0.2352 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the shares subject to the option vest one year after the date of grant, on 2/24/2023, and the remaining 1/36 of the shares vest on a monthly basis thereafter.